Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT 327 cream in mild to moderate atopic dermatitis
NCT00996008Phase 2Terminated
- Sponsor
- Creabilis SA
- Start
- Nov 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pegcantratinib in atopic dermatitis (AD), sponsored by Creabilis SA. Started Nov 2009; status: terminated.
02
Drugs
pegcantratinib
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00996008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00996008.